FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I) or a stereoisomer thereof:
where A is selected from a group consisting of a phenyl ring, ,
,
,
,
and
; R1 is selected from a group consisting of a hydrogen atom, fluorine, chlorine, bromine, cyano, difluoroethyl and trifluoroethyl; m is 0, 1 or 2; W is O; R2 is selected from the group consisting of a hydrogen atom, chlorine, cyano, trifluoromethyl, methoxy and methoxymethyl; R3 is selected from the group consisting of a fluorine atom, hydroxyl, oxo (= O), methyl, fluoromethyl and methoxymethyl; q is 0 or 1; X is CH or N; Y is CH or N; R5 is methyl; R4 is oxetan-2-ylmethyl; in
Z1 is CH; Z2 is CH; Z3 is CH or N; and in
Z1 is N, Z2 is CH, or N, or CF, and Z3 is CH or CF, as well as to a pharmaceutical composition and use of a compound of formula (I) for preparing a medicament for treating diseases associated with GLP-1.
EFFECT: novel compounds which can be used for preparing a drug for treating GLP-1-associated diseases, especially those associated with diabetes mellitus, are obtained.
9 cl, 3 tbl, 55 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION CONTAINING IT AND A METHOD OF ITS PREPARATION | 2021 |
|
RU2800290C1 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN MEDICINAL PREPARATIONS | 2014 |
|
RU2694254C1 |
MODULATORS OF NUCLEAR RECEPTORS | 2016 |
|
RU2715897C2 |
HETEROCYCLIC COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2667498C2 |
GLP-1 RECEPTOR AGONISTS AND USE THEREOF | 2017 |
|
RU2740135C1 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
GLP-1 RECEPTOR AGONISTS AND APPLICATION THEREOF | 2019 |
|
RU2765721C1 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
Authors
Dates
2024-12-23—Published
2021-11-26—Filed